Showing results (61-70 of 263) with videos related to
Sort By:
Pageof 27
Cancers|April 3, 2021
Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic MitigationsKristen Renee McSweeney, Laura Kate Gadanec, Tawar Qaradakhi, et al.Nutrients|September 22, 2020
The Anti-Inflammatory Effect of Taurine on Cardiovascular DiseaseTawar Qaradakhi, Laura Kate Gadanec, Kristen Renee McSweeney, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 20, 2017
H2S causes contraction and relaxation of major arteries of the rabbitMartin Caprnda, Tawar Qaradakhi, Joanne L Hart, et al.Heart, Lung & Circulation|April 18, 2020
The Prevalence of Elevated Lipoprotein(a) in Patients Presenting With Coronary Artery DiseaseHnin P Oo, Julian Giovannucci, Richard C O'Brien, et al.Psychosomatics|September 13, 2011
A psychometric evaluation of the Chinese version of the short-form cardiac depression scaleWenru Wang, Chantal F Ski, David R Thompson, et al.Clinical Journal of the American Society of Nephrology : CJASN|April 12, 2014
Temporal trajectory of B-type natriuretic peptide in patients with CKD stages 3 and 4, dialysis, and kidney transplantMatthew A Roberts, David L Hare, Ken Sikaris, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 26, 2006
Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac diseaseMatthew A Roberts, David L Hare, Sujiva Ratnaike, et al.Journal of Cardiopulmonary Rehabilitation and Prevention|November 15, 2008
Patterns of psychosocial adjustment following cardiac surgeryNatalie Genardini, Sarah J Wilson, Jeanette A Lawrence, et al.International Journal of Cardiology|January 15, 2008
Functional capacity and quality of life in middle-age men and women with high and low number of metabolic risk factorsItamar Levinger, Craig Goodman, David L Hare, et al.BMC Research Notes|September 25, 2014
A nurse-led up-titration clinic improves chronic heart failure optimization of beta-adrenergic receptor blocking therapy--a randomized controlled trialAndrea Driscoll, Piyush Srivastava, Deidre Toia, et al.Pageof 27